: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

COVID-19

Free Subscription

Articles published in J Virol
Retrieve available abstracts of 423 articles:
HTML format

Single Articles

October 2025

WANG W, Du P, Zhao Y, Liang Y, et al
Biomimetic nanovaccines with self-adjuvant effects induced broad-spectrum neutralizing antibodies against SARS-CoV-2 infection in rodents.
J Virol. 2025 Oct 10:e0031525. doi: 10.1128/jvi.00315.
PubMed Abstract available

MITCHELL JK, Mastrodomenico V, Hartnett J, Heelan WJ, et al
A HiBiT-tagged pseudovirus-like particle platform for safe, rapid quantification of virus neutralization and antibody-dependent enhancement.
J Virol. 2025 Oct 8:e0099125. doi: 10.1128/jvi.00991.
PubMed Abstract available

PERRY JK, Itskanov S, Bilello JP, Lansdon EB, et al
A structural roadmap for the formation of the coronavirus nsp3/nsp4 double membrane vesicle pore and its implications for polyprotein processing and replication/transcription.
J Virol. 2025 Oct 8:e0145725. doi: 10.1128/jvi.01457.
PubMed Abstract available

ZAIB W, Kaviani C, Kang X, Gao Y, et al
Porcine hemagglutinating encephalomyelitis virus VW572 (not Gent/PS412 and Labadie) uses the CD81 receptor and MVB-derived exosomal pathway for efficient entry and spread in neuronal cells.
J Virol. 2025 Oct 8:e0117125. doi: 10.1128/jvi.01171.
PubMed Abstract available

PAN Z, Jiang L, Chen Y, Peng H, et al
Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations.
J Virol. 2025 Oct 3:e0109925. doi: 10.1128/jvi.01099.
PubMed Abstract available

September 2025

BRANT AC, Hu Z, Chen AZ, Majerciak V, et al
Discontinuous template switching generates coronavirus subgenomic RNAs from the 3' viral genome end by 5' to 3' transcription.
J Virol. 2025 Sep 25:e0143825. doi: 10.1128/jvi.01438.
PubMed Abstract available

TSUJINO S, Tsuda M, Nao N, Okumura K, et al
Evolution of BA.2.86 to JN.1 reveals that functional changes in non-structural viral proteins are required for fitness of SARS-CoV-2.
J Virol. 2025 Sep 23:e0090825. doi: 10.1128/jvi.00908.
PubMed Abstract available

HAMMER E, Flynn C, Rossler J, Erder J, et al
Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry.
J Virol. 2025 Sep 23:e0118925. doi: 10.1128/jvi.01189.
PubMed Abstract available

CHIOK KL, Jenik K, Fenton M, Falzarano D, et al
MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures.
J Virol. 2025 Sep 18:e0109825. doi: 10.1128/jvi.01098.
PubMed Abstract available

JIAN X, Hu T, Xu H, Wen Y, et al
An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.
J Virol. 2025 Sep 16:e0117225. doi: 10.1128/jvi.01172.
PubMed Abstract available

FARRUKEE R, Mordant F, Mackenzie-Kludas C, Mesner D, et al
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.
J Virol. 2025 Sep 15:e0082325. doi: 10.1128/jvi.00823.
PubMed Abstract available

WANG J, Sang X, Zheng W, Chan JF-W, et al
Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main protease.
J Virol. 2025 Sep 15:e0065825. doi: 10.1128/jvi.00658.
PubMed Abstract available

WESTON S, Baracco L, Taylor L, Scott AJ, et al
The mammalian SKI complex is a broad-spectrum antiviral drug target that upregulates cellular cholesterol to inhibit viral replication.
J Virol. 2025 Sep 10:e0132325. doi: 10.1128/jvi.01323.
PubMed Abstract available

LIZCANO-PERRET B, Wavreil F, Veinstein M, Duflos C, et al
The leader proteins of Theiler's virus and Boone cardiovirus use a combination of short linear motifs (SLiMs) to target RSK kinases to the nuclear pore complex.
J Virol. 2025 Sep 10:e0127525. doi: 10.1128/jvi.01275.
PubMed Abstract available

JIAO Z, Li J, Wang P, Yan Y, et al
Mutations in feline infectious peritonitis virus nonstructural protein 14/16 methyltransferase attenuate the pathogenicity of the virus in cats.
J Virol. 2025 Sep 9:e0083925. doi: 10.1128/jvi.00839.
PubMed Abstract available

KASLE G, Sharma M, Kumar S, Das P, et al
Phenylbutyrate restricts murine beta-coronavirus infectivity and limits virus-induced demyelination in vivo.
J Virol. 2025 Sep 8:e0081925. doi: 10.1128/jvi.00819.
PubMed Abstract available

JOSEPH R, Marais G, Iranzadeh I, Alisoltani A, et al
Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2.
J Virol. 2025 Sep 5:e0078025. doi: 10.1128/jvi.00780.
PubMed Abstract available

GRACIE NP, Aggarwal A, Luo R, Spicer M, et al
An RGD motif on SARS-CoV-2 Spike induces TGF-beta signaling and downregulates interferon.
J Virol. 2025 Sep 4:e0043525. doi: 10.1128/jvi.00435.
PubMed Abstract available

August 2025

WANG Y, Peng D, Li M, Yao M, et al
Organoids: physiologically relevant ex vivo models for viral disease research.
J Virol. 2025 Aug 29:e0113225. doi: 10.1128/jvi.01132.
PubMed Abstract available

VERMA A, Kamboj H, Kumar G, Khandelwal N, et al
TGF-beta inhibitor SB431542 suppresses SARS-CoV-2 replication through multistep inhibition.
J Virol. 2025 Aug 29:e0052925. doi: 10.1128/jvi.00529.
PubMed Abstract available

GARTNER MJ, Smith ML, Dapat C, Liaw YW, et al
Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strains.
J Virol. 2025 Aug 27:e0068425. doi: 10.1128/jvi.00684.
PubMed Abstract available

HE Q, Zou Y, Yu B, Yuan Q, et al
A novel nanoparticle vaccine, based on S1-CTD, elicits robust protective immune responses against porcine deltacoronavirus.
J Virol. 2025 Aug 21:e0067425. doi: 10.1128/jvi.00674.
PubMed Abstract available

CHI X, Liang X, Vaddadi K, Zhang X, et al
SARS-CoV-2 Nsp15 endoribonuclease subverts host defenses to enhance viral fitness in lung cells.
J Virol. 2025 Aug 21:e0117525. doi: 10.1128/jvi.01175.
PubMed Abstract available

ZHANG H, Deng X, Dai R, Fu J, et al
Inadequate immune response to inactivated COVID-19 vaccine among older people living with HIV: a prospective cohort study.
J Virol. 2025 Aug 21:e0068825. doi: 10.1128/jvi.00688.
PubMed Abstract available

EL ZOWALATY ME, Taylor LJ, Son Y, Lee H, et al
Discovery, phylogenetic, and comparative genomic analysis of novel avian gammacoronaviruses identified in feral pigeons (Columba livia domestica).
J Virol. 2025 Aug 20:e0111225. doi: 10.1128/jvi.01112.
PubMed Abstract available

HU J, Zheng H, Ran W, Wang X, et al
Mucosal vaccination with long-form TSLP induces migratory cDC1-mediated adaptive immunity against SARS-CoV-2 infection.
J Virol. 2025 Aug 19:e0123125. doi: 10.1128/jvi.01231.
PubMed Abstract available

YANG L, Qian Q, Sun Y-g, Chen X-x, et al
PEDV Nsp14 induces mitophagy-mediated degradation of MAVS to antagonize host innate immunity and facilitate viral proliferation.
J Virol. 2025;99:e0049825.
PubMed Abstract available

SUGIURA Y, Takahashi T, Ueno S, Amarbayasgalan S, et al
Expression of spike and hemagglutinin-esterase proteins is necessary to recover infectious recombinant bovine coronavirus.
J Virol. 2025 Aug 11:e0102725. doi: 10.1128/jvi.01027.
PubMed Abstract available

XIAO W, Xiong Y, Wang Y, Li T, et al
Cathepsin L and transmembrane serine protease 11E mediate trypsin-independent entry of porcine deltacoronavirus into Huh7 cells.
J Virol. 2025 Aug 11:e0105525. doi: 10.1128/jvi.01055.
PubMed Abstract available

KARIMI A, Lieber CM, Sakamoto K, Plemper RK, et al
SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters.
J Virol. 2025 Aug 11:e0075525. doi: 10.1128/jvi.00755.
PubMed Abstract available

SOWNTHIRARAJAN B, Mason M, Loganathan G, Manivasagam S, et al
A versatile H5N1-VSV platform for safe influenza virus research applications.
J Virol. 2025 Aug 8:e0097525. doi: 10.1128/jvi.00975.
PubMed Abstract available

MA Y, Ye C, Khalil AM, Mahmoud SH, et al
A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.
J Virol. 2025 Aug 7:e0082125. doi: 10.1128/jvi.00821.
PubMed Abstract available

YU R, Bai Y, Zhang L, Zhou P, et al
Single self-cleaving mRNA vaccine expressing multiple viral structural proteins elicits robust immune responses and protects nursing piglets against PDCoV infection.
J Virol. 2025 Aug 6:e0084925. doi: 10.1128/jvi.00849.
PubMed Abstract available

July 2025

O'CONNOR JJ, Roy A, Khattabi R, Kerr C, et al
Mutations differentially affecting the coronavirus Mac1 ADP-ribose binding and hydrolysis activities indicate that it promotes multiple stages of the viral replication cycle.
J Virol. 2025 Jul 30:e0062325. doi: 10.1128/jvi.00623.
PubMed Abstract available

ZHAO Y, Guo G, Sun Y, Zhang M, et al
Membrane protein CRISPR screen identifies RPSA as an essential host factor for porcine epidemic diarrhea virus replication.
J Virol. 2025 Jul 30:e0064925. doi: 10.1128/jvi.00649.
PubMed Abstract available

LI Q, Cai X, Li X, Zhang Y, et al
Structural and functional constraints on spike activation and host protease utilization limit cell entry of SARS-CoV-2-related bat coronaviruses.
J Virol. 2025 Jul 24:e0100725. doi: 10.1128/jvi.01007.
PubMed Abstract available

CARLOCK MA, Pierce SR, Ross TM
Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses.
J Virol. 2025 Jul 15:e0070525. doi: 10.1128/jvi.00705.
PubMed Abstract available

XU Z, Li L, Gu Y, Li D, et al
CX1/BtSY2 and BANAL-20-52 exhibit broader receptor binding and higher affinities to multiple animal ACE2 orthologs than SARS-CoV-2 prototype.
J Virol. 2025 Jul 10:e0028325. doi: 10.1128/jvi.00283.
PubMed Abstract available

June 2025

POWELL BH, Witwer KW, Meffert MK
Cellular miRNAs and viruses: trends in miRNA sequestering and target de-repression.
J Virol. 2025 Jun 18:e0091425. doi: 10.1128/jvi.00914.
PubMed Abstract available

CHEN Y, Shi Y, Zuo X, Dong X, et al
UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation.
J Virol. 2025 Jun 18:e0074125. doi: 10.1128/jvi.00741.
PubMed Abstract available

MATSUGO H, Kitamura T, Takahashi N, Chambers J, et al
In vitro and in vivo characterization of a bat merbecovirus with ACE2- and DPP4-independent cell entry.
J Virol. 2025 Jun 17:e0072725. doi: 10.1128/jvi.00727.
PubMed Abstract available

HARRIS C, Kapingidza AB, San JE, Christopher J, et al
Design of SARS-CoV-2 RBD immunogens to focus immune responses toward conserved coronavirus epitopes.
J Virol. 2025 Jun 13:e0046525. doi: 10.1128/jvi.00465.
PubMed Abstract available

LI C, Shi Y, Xie C, Duan K, et al
GSDMD and GSDME exhibit distinct roles in enteric coronavirus PDCoV-induced pyroptosis and inflammatory responses.
J Virol. 2025 Jun 12:e0187624. doi: 10.1128/jvi.01876.
PubMed Abstract available

LOKUGAMAGE KG, Zhou Y, Alvarado RE, Plante JA, et al
Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection.
J Virol. 2025 Jun 12:e0209124. doi: 10.1128/jvi.02091.
PubMed Abstract available

COTTIGNIES-CALAMARTE A, Marteau F, He F, Belouzard S, et al
Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response.
J Virol. 2025 Jun 12:e0039425. doi: 10.1128/jvi.00394.
PubMed Abstract available

LIU M, Aryal B, Niu X, Wang Q, et al
Engineering a recombination-resistant live attenuated vaccine candidate with suppressed interferon antagonists for PEDV.
J Virol. 2025 Jun 12:e0045125. doi: 10.1128/jvi.00451.
PubMed Abstract available

MORGAN AL, Vu MN, Zhou Y, Lokugamage KG, et al
The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2.
J Virol. 2025 Jun 10:e0046725. doi: 10.1128/jvi.00467.
PubMed Abstract available

FOSTER CSP, Walker GJ, Jean T, Wong M, et al
Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution.
J Virol. 2025 Jun 9:e0036325. doi: 10.1128/jvi.00363.
PubMed Abstract available

LI Y, Duan L, Tang L, Huang M, et al
Rapid reconstruction of infectious bronchitis virus expressing fluorescent protein from its nsp2 gene based on transformation-associated recombination platform.
J Virol. 2025 Jun 5:e0053525. doi: 10.1128/jvi.00535.
PubMed Abstract available

NGUYEN D, Laidlaw SM, Dong X, Wand M, et al
SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.
J Virol. 2025 Jun 4:e0051925. doi: 10.1128/jvi.00519.
PubMed Abstract available

May 2025

WANG Y, Tong W, Qin W, Yang X, et al
Midnolin inhibits coronavirus proliferation by degrading viral proteins.
J Virol. 2025 May 29:e0036625. doi: 10.1128/jvi.00366.
PubMed Abstract available

GUO L, Duan X, Li J, Hao Z, et al
YIPF5 is an essential host factor for porcine epidemic diarrhea virus double-membrane vesicle formation.
J Virol. 2025 May 27:e0032025. doi: 10.1128/jvi.00320.
PubMed Abstract available

POGANY J, Inaba J-i, Liu Y, Nagy PD, et al
Screening bacterial effectors and human virus proteins in yeast to identify host factors driving tombusvirus RNA recombination: a role for autophagy and membrane phospholipid content.
J Virol. 2025 May 27:e0166124. doi: 10.1128/jvi.01661.
PubMed Abstract available

QIAN Q, Zhao S-s, Yang L, Xing G, et al
Palmitoylation enhances the stability of porcine epidemic diarrhea virus spike protein by antagonizing its degradation via chaperone-mediated autophagy to facilitate viral proliferation.
J Virol. 2025 May 22:e0034725. doi: 10.1128/jvi.00347.
PubMed Abstract available

WANG Y, Cheng Y, Wang S, Liu D, et al
Unraveling the cross-talk between a highly virulent PEDV strain and the host via single-cell transcriptomic analysis.
J Virol. 2025 May 21:e0055525. doi: 10.1128/jvi.00555.
PubMed Abstract available

BEAN DJ, Liang YM, Avila F, He X, et al
Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.
J Virol. 2025 May 19:e0055025. doi: 10.1128/jvi.00550.
PubMed Abstract available

BROADBENT A
A veterinary virapalooza: a summary of the 2024 American Society for Virology (ASV) Veterinary/Zoonotic Virology Satellite Symposium and online H5N1 panel discussion.
J Virol. 2025 May 13:e0049925. doi: 10.1128/jvi.00499.
PubMed Abstract available

FURUSAWA Y, Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y, et al
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.
J Virol. 2025 May 13:e0065625. doi: 10.1128/jvi.00656.
PubMed Abstract available

KONDO T, Suzuki R, Yajima H, Kawahara S, et al
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.
J Virol. 2025 May 12:e0054325. doi: 10.1128/jvi.00543.
PubMed Abstract available

FRIEDLANDER AM
Early short-course treatment fails to prevent disease or relapse upon discontinuance of treatment in infections in addition to COVID-19.
J Virol. 2025 May 12:e0038125. doi: 10.1128/jvi.00381.
PubMed

LV L, Luo H, Yi J, Zhang K, et al
IFITM proteins are key entry factors for porcine epidemic diarrhea coronavirus.
J Virol. 2025 May 12:e0202824. doi: 10.1128/jvi.02028.
PubMed Abstract available

DAI J, Feng Y, Long H, Liao Y, et al
Dexamethasone disrupts intracellular pH homeostasis to delay coronavirus infectious bronchitis virus cell entry via sodium hydrogen exchanger 3 activation.
J Virol. 2025 May 9:e0189424. doi: 10.1128/jvi.01894.
PubMed Abstract available

LUGANO D, Mwangi K, Mware B, Kibet G, et al
Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.
J Virol. 2025 May 6:e0048225. doi: 10.1128/jvi.00482.
PubMed Abstract available

April 2025

ZHANG S, Xu C-L, Wang J, Xiong X, et al
Spike proteins of coronaviruses activate mast cells for degranulation via stimulating Src/PI3K/AKT/Ca(2+) intracellular signaling cascade.
J Virol. 2025 Apr 30:e0007825. doi: 10.1128/jvi.00078.
PubMed Abstract available

NEGI V, Kuhn RJ
A BSL-2 chimeric system designed to screen SARS-CoV-2 E protein ion channel inhibitors.
J Virol. 2025 Apr 30:e0225224. doi: 10.1128/jvi.02252.
PubMed Abstract available

SUN H, Yang Q, Zhang Y, Cui S, et al
Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes.
J Virol. 2025 Apr 25:e0000225. doi: 10.1128/jvi.00002.
PubMed Abstract available

DE AVILA AI, Soria ME, Martinez-Gonzalez B, Somovilla P, et al
SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.
J Virol. 2025 Apr 24:e0225024. doi: 10.1128/jvi.02250.
PubMed Abstract available

MATTHEWS L, Cook J, Stephan R, Milacic M, et al
Advancing curation of viral life cycles, host interactions, and therapeutics in Reactome.
J Virol. 2025 Apr 23:e0202424. doi: 10.1128/jvi.02024.
PubMed Abstract available

COX JB, Nukui M, Murphy EA
Protein-S-nitrosylation of human cytomegalovirus pp65 reduces its ability to undermine cGAS.
J Virol. 2025 Apr 17:e0048125. doi: 10.1128/jvi.00481.
PubMed Abstract available

LI Y, Yang S, Qian J, Liu S, et al
Molecular characteristics of the immune escape of coronavirus PEDV under the pressure of vaccine immunity.
J Virol. 2025 Apr 16:e0219324. doi: 10.1128/jvi.02193.
PubMed Abstract available

KAWAKITA T, Sekiya T, Kameda Y, Nomura N, et al
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4(+) and CD8(+) T-cell responses and neutralizing antibody induction.
J Virol. 2025 Apr 15:e0229024. doi: 10.1128/jvi.02290.
PubMed Abstract available

XIE H, Xiong T, Guan J, Han Y, et al
Induction of mitochondrial damage via the CREB3L1/miR-34c/COX1 axis by porcine epidemic diarrhea virus infection facilitates pathogenicity.
J Virol. 2025;99:e0059124.
PubMed Abstract available

ZHOU B, Gui Q, Liu C, Guo H, et al
Structure and function of an unusual R452-dependent monoclonal antibody against SARS-CoV-2.
J Virol. 2025 Apr 8:e0184424. doi: 10.1128/jvi.01844.
PubMed Abstract available

XIAO X, Li S, Zheng Z, Ji Y, et al
Targeting USP22 to promote K63-linked ubiquitination and degradation of SARS-CoV-2 nucleocapsid protein.
J Virol. 2025 Apr 4:e0223424. doi: 10.1128/jvi.02234.
PubMed Abstract available

March 2025

GHIMIRE R, Shrestha R, Amaradhi R, Liu L, et al
Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection.
J Virol. 2025 Mar 31:e0166824. doi: 10.1128/jvi.01668.
PubMed Abstract available

NOETTGER S, Zech F, Nchioua R, Pastorio C, et al
Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.
J Virol. 2025 Mar 28:e0220224. doi: 10.1128/jvi.02202.
PubMed Abstract available

KRAMMER F, Hermann E, Rasmussen AL
Highly pathogenic avian influenza H5N1: history, current situation, and outlook.
J Virol. 2025 Mar 27:e0220924. doi: 10.1128/jvi.02209.
PubMed Abstract available

JANA ID, Kanjo K, Roy S, Bhasin M, et al
Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants.
J Virol. 2025 Mar 26:e0005125. doi: 10.1128/jvi.00051.
PubMed Abstract available

ZHANG S, Cao Y, Huang Y, Zhang X, et al
Abortive PDCoV infection triggers Wnt/beta-catenin pathway activation, enhancing intestinal stem cell self-renewal and promoting chicken resistance.
J Virol. 2025 Mar 26:e0013725. doi: 10.1128/jvi.00137.
PubMed Abstract available

LI P, Faraone JN, Hsu CC, Chamblee M, et al
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.
J Virol. 2025 Mar 26:e0024225. doi: 10.1128/jvi.00242.
PubMed Abstract available

JOHN K, Huntress I, Smith E, Chou H, et al
Human long noncoding RNA VILMIR is induced by major respiratory viral infections and modulates the host interferon response.
J Virol. 2025 Mar 25:e0014125. doi: 10.1128/jvi.00141.
PubMed Abstract available

DADONAITE B, Burrell AR, Logue J, Chu HY, et al
SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.
J Virol. 2025 Mar 25:e0010925. doi: 10.1128/jvi.00109.
PubMed Abstract available

BEAVIS AC, Xiao P, Gingerich MC, Briggs K, et al
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.
J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990.
PubMed Abstract available

BEAVIS AC, Li Z, Briggs K, Gingerich MC, et al
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.
J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989.
PubMed Abstract available

SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al
SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077.
PubMed Abstract available

ZHONG Q, Qi J, Su N, Li Z, et al
In vivo investigation of PEDV transmission via nasal infection: mechanisms of CD4(+) T-cell-mediated intestinal infection.
J Virol. 2025 Mar 17:e0176124. doi: 10.1128/jvi.01761.
PubMed Abstract available

HU H, Zhang Y, Zheng H, Zhao X, et al
Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response.
J Virol. 2025 Mar 4:e0232324. doi: 10.1128/jvi.02323.
PubMed Abstract available

MA Z, Li Z, Li Y, Zhao X, et al
Changes in the motifs in the D0 and SD2 domains of the S protein drive the evolution of virulence in enteric coronavirus porcine epidemic diarrhea virus.
J Virol. 2025 Mar 4:e0209224. doi: 10.1128/jvi.02092.
PubMed Abstract available

KARL V, Hofmann M, Thimme R
Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination.
J Virol. 2025 Mar 3:e0135024. doi: 10.1128/jvi.01350.
PubMed Abstract available

February 2025

KEEP S, Foldes K, Dowgier G, Freimanis G, et al
Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge.
J Virol. 2025 Feb 27:e0166324. doi: 10.1128/jvi.01663.
PubMed Abstract available

LI W, Hangalapura BN, van den Elzen P, van den Born E, et al
Spike gene variability in porcine epidemic diarrhea virus as a determinant for virulence.
J Virol. 2025 Feb 26:e0216524. doi: 10.1128/jvi.02165.
PubMed Abstract available

QIN W, Kong N, Xie S, Liu H, et al
RNASEK interacting with PEDV structural proteins facilitates virus entry via clathrin-mediated endocytosis.
J Virol. 2025;99:e0176024.
PubMed Abstract available

SOULTSIOTI M, de Jong AWM, Blomberg N, Tas A, et al
Perturbation of de novo lipogenesis hinders MERS-CoV assembly and release, but not the biogenesis of viral replication organelles.
J Virol. 2025 Feb 20:e0228224. doi: 10.1128/jvi.02282.
PubMed Abstract available

MA R, Zhang X, Li R, Dong X, et al
PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085.
PubMed Abstract available

ZHU H, Lou J, Yang Z, Bai J, et al
STT3B promotes porcine epidemic diarrhea virus replication by regulating N-glycosylation of PEDV S protein.
J Virol. 2025 Feb 13:e0001825. doi: 10.1128/jvi.00018.
PubMed Abstract available

FURUSAWA Y, Kiso M, Uraki R, Sakai-Tagawa Y, et al
Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures.
J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217.
PubMed Abstract available

CAO X, Liu Y, Tong W, Qin W, et al
POLM inhibits porcine epidemic diarrhea virus replication by degrading multiple viral structural proteins.
J Virol. 2025 Feb 10:e0227824. doi: 10.1128/jvi.02278.
PubMed Abstract available

KUHN AJ, Outlaw VK, Marcink TC, Yu Z, et al
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development.
J Virol. 2025 Feb 4:e0215924. doi: 10.1128/jvi.02159.
PubMed Abstract available

PHAN T, Ribeiro RM, Edelstein GE, Boucau J, et al
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.
J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
PubMed Abstract available

WANG X, Dong M, Wu X, Schnepf D, et al
Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice.
J Virol. 2025 Feb 4:e0141324. doi: 10.1128/jvi.01413.
PubMed Abstract available

PARK H, Kingstad-Bakke B, Cleven T, Jung M, et al
Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein.
J Virol. 2025 Feb 3:e0086724. doi: 10.1128/jvi.00867.
PubMed Abstract available

January 2025

SAMAAN P, Korosec CS, Budylowski P, Chau SLL, et al
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.
J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685.
PubMed Abstract available

LIU C, Kong N, Liu H, Zhang Y, et al
FSTL1 and TLR4 interact with PEDV structural proteins to promote virus adsorption to host cells.
J Virol. 2025;99:e0183724.
PubMed Abstract available

DUGUAY BA, Tooley TH, Pringle ES, Rohde JR, et al
A yeast-based reverse genetics system to generate HCoV-OC43 reporter viruses encoding an eighth subgenomic RNA.
J Virol. 2025 Jan 30:e0167124. doi: 10.1128/jvi.01671.
PubMed Abstract available

LYTRAS S, Lamb KD, Ito J, Grove J, et al
Pathogen genomic surveillance and the AI revolution.
J Virol. 2025 Jan 29:e0160124. doi: 10.1128/jvi.01601.
PubMed Abstract available

WANG Y, Xia B, Gao Z
A comprehensive review of current insights into the virulence factors of SARS-CoV-2.
J Virol. 2025 Jan 29:e0204924. doi: 10.1128/jvi.02049.
PubMed Abstract available

CHEN R, Zhou G, Yang J, Yuan R, et al
A novel neutralizing antibody recognizing a conserved conformational epitope in PDCoV S1 protein and its therapeutic efficacy in piglets.
J Virol. 2025 Jan 22:e0202524. doi: 10.1128/jvi.02025.
PubMed Abstract available

HASEGAWA N, Nishimura M, Takamiya R, Ishimaru H, et al
SARS-CoV-2 BA.2.86 is susceptible to the neutralizing antibody MO11 targeting subdomain 1 despite the E554K mutation near the epitope.
J Virol. 2025 Jan 22:e0138924. doi: 10.1128/jvi.01389.
PubMed

LIANG R, Tian J, Liu K, Ma L, et al
The cytoplasmic tail of IBV spike mediates intracellular retention via interaction with COPI-coated vesicles in retrograde trafficking.
J Virol. 2025 Jan 22:e0216424. doi: 10.1128/jvi.02164.
PubMed Abstract available

NAGHIBOSADAT M, Babuadze GG, Pei Y, Hurst J, et al
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models.
J Virol. 2025 Jan 16:e0139024. doi: 10.1128/jvi.01390.
PubMed Abstract available

CAI C, Pham TNQ, Adam D, Brochiero E, et al
Sensing of SARS-CoV-2-infected cells by plasmacytoid dendritic cells is modulated via an interplay between CD54/ICAM-1 and CD11a/LFA-1 alpha(L) integrin.
J Virol. 2025 Jan 13:e0123524. doi: 10.1128/jvi.01235.
PubMed Abstract available

GRIMES SL, Heaton BE, Anderson ML, Burke K, et al
The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity.
J Virol. 2025 Jan 10:e0170824. doi: 10.1128/jvi.01708.
PubMed Abstract available

ARORA P, Zhang L, Nehlmeier I, Kempf A, et al
Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
J Virol. 2025 Jan 10:e0123024. doi: 10.1128/jvi.01230.
PubMed Abstract available

HU H, Leng C, Shu Y, Peng L, et al
Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2.
J Virol. 2025 Jan 7:e0130724. doi: 10.1128/jvi.01307.
PubMed Abstract available

GUNAWARDENE CD, Wong L-YR
Betacoronavirus internal protein: role in immune evasion and viral pathogenesis.
J Virol. 2025 Jan 6:e0135324. doi: 10.1128/jvi.01353.
PubMed Abstract available

December 2024

ZHU J, Lai Y, Cheng M, Dash RC, et al
Discovery of small molecules against porcine reproductive and respiratory syndrome virus replication by targeting NendoU activity.
J Virol. 2024 Dec 31:e0203424. doi: 10.1128/jvi.02034.
PubMed Abstract available

CAI Z, Ni W, Li W, Wu Z, et al
SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response.
J Virol. 2024 Dec 19:e0151624. doi: 10.1128/jvi.01516.
PubMed Abstract available

CARDANI-BOULTON A, Lin F, Bergmann CC
CD6 regulates CD4 T follicular helper cell differentiation and humoral immunity during murine coronavirus infection.
J Virol. 2024 Dec 16:e0186424. doi: 10.1128/jvi.01864.
PubMed Abstract available

BARBOSA BOMFIM CC, Genin H, Cottoignies-Callamarte A, Gallois-Montbrun S, et al
Erratum for Barbosa Bomfim et al., "CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients".
J Virol. 2024 Dec 10:e0200624. doi: 10.1128/jvi.02006.
PubMed

ZHANG Y, Zhang N, Zhang Y, Li Y, et al
Potassium molybdate blocks APN-dependent coronavirus entry by degrading receptor via PIK3C3-mediated autophagy.
J Virol. 2024 Dec 6:e0144924. doi: 10.1128/jvi.01449.
PubMed Abstract available

ZUO F, Cao Y, Sun R, Wang Q, et al
Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.
J Virol. 2024 Dec 4:e0174024. doi: 10.1128/jvi.01740.
PubMed

November 2024

KAKIZAKI M, Hashimoto R, Nagata N, Yamamoto T, et al
The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
J Virol. 2024 Nov 27:e0185324. doi: 10.1128/jvi.01853.
PubMed Abstract available

BOLLAND W, Marechal I, Petiot C, Porrot F, et al
SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
J Virol. 2024 Nov 21:e0182324. doi: 10.1128/jvi.01823.
PubMed Abstract available

PATINO-GALINDO J, Garcia-Sastre A, Kuhn JH, Rabadan R, et al
Recombination across distant coronavirid species and genera is a rare event with distinct genomic features.
J Virol. 2024 Nov 19:e0110024. doi: 10.1128/jvi.01100.
PubMed Abstract available

CHEN Y, Ou X, Li P, Zan F, et al
Identification of the critical residues of TMPRSS2 for entry and host range of human coronavirus HKU1.
J Virol. 2024 Nov 11:e0158724. doi: 10.1128/jvi.01587.
PubMed Abstract available

STEIGMANN JC, Zhou X, Suttenberg LN, Salman I, et al
Effects of immunoproteasome inhibition on acute respiratory infection with murine hepatitis virus strain 1.
J Virol. 2024 Nov 7:e0123824. doi: 10.1128/jvi.01238.
PubMed Abstract available

CHEN D, Zhang W, Xiao B, Xu B, et al
Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk.
J Virol. 2024 Nov 5:e0128524. doi: 10.1128/jvi.01285.
PubMed Abstract available

STEIN SC, Hansen G, Ssebyatika G, Stroh LJ, et al
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
J Virol. 2024 Nov 4:e0122324. doi: 10.1128/jvi.01223.
PubMed Abstract available

PARRY RH, Lytras S, Petrone ME, Wille M, et al
No evidence that mutations in SARS-CoV-2 variants of concern derive from homologous fragments in gut microbiota.
J Virol. 2024 Nov 4:e0146824. doi: 10.1128/jvi.01468.
PubMed Abstract available

October 2024

LIU X, Zhang M, Yin L, Kang L, et al
PEDV evades MHC-I-related immunity through nsp1-mediated NLRC5 translation inhibition.
J Virol. 2024 Oct 31:e0142124. doi: 10.1128/jvi.01421.
PubMed Abstract available

SHI L, Duan Y, Cao L, Zhang Y, et al
PF-00835231 broadly inhibits swine Alpha-coronavirus, including emerging SADS-CoV.
J Virol. 2024 Oct 31:e0130324. doi: 10.1128/jvi.01303.
PubMed Abstract available

HOFFMANN M, Kleine-Weber H, Graichen L, Nehlmeier I, et al
Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells.
J Virol. 2024 Oct 29:e0130524. doi: 10.1128/jvi.01305.
PubMed Abstract available

ZHANG C, Jiang Q, Liu Z, Li N, et al
SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor.
J Virol. 2024 Oct 24:e0075424. doi: 10.1128/jvi.00754.
PubMed Abstract available

CAILLAVA AJ, Alfonso V, Tejerina Cibello M, Demaria MA, et al
A vaccine candidate based on baculovirus displaying chikungunya virus E1-E2 envelope confers protection against challenge in mice.
J Virol. 2024 Oct 23:e0101724. doi: 10.1128/jvi.01017.
PubMed Abstract available

HAN Y, Zhou H, Liu C, Wang W, et al
SARS-CoV-2 N protein coordinates viral particle assembly through multiple domains.
J Virol. 2024 Oct 16:e0103624. doi: 10.1128/jvi.01036.
PubMed Abstract available

ZHANG D, Xie Y, Liao Q, Jiao Z, et al
Development of a safe and broad-spectrum attenuated PEDV vaccine candidate by S2 subunit replacement.
J Virol. 2024 Oct 15:e0042924. doi: 10.1128/jvi.00429.
PubMed Abstract available

KERR CM, Pfannenstiel JJ, Alhammad YM, O'Connor JJ, et al
Mutation of a highly conserved isoleucine residue in loop 2 of several beta-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication.
J Virol. 2024 Oct 10:e0131324. doi: 10.1128/jvi.01313.
PubMed Abstract available

LI A, Zhao K, Duan Y, Zhang B, et al
SARS-CoV-2 nsp13 suppresses hepatitis B virus replication by targeting cccDNA transcription.
J Virol. 2024 Oct 7:e0104224. doi: 10.1128/jvi.01042.
PubMed Abstract available

WANG W, Bhushan G, Paz S, Stauft CB, et al
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.
J Virol. 2024 Oct 4:e0094824. doi: 10.1128/jvi.00948.
PubMed Abstract available

September 2024

KANG JS, Zhou K, Wang H, Tang S, et al
Architectural organization and in situ fusion protein structure of lymphocytic choriomeningitis virus.
J Virol. 2024 Sep 27:e0064024. doi: 10.1128/jvi.00640.
PubMed Abstract available

WANG Z, Qiu M, Ji Y, Chai K, et al
Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation.
J Virol. 2024 Sep 17:e0107224. doi: 10.1128/jvi.01072.
PubMed Abstract available

BROOKS K, Nelson CE, Aguilar C, Hoang TN, et al
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier.
J Virol. 2024 Sep 12:e0128824. doi: 10.1128/jvi.01288.
PubMed Abstract available

SONG X, Li Y, Wang C, Zhao Y, et al
Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection.
J Virol. 2024 Sep 10:e0130924. doi: 10.1128/jvi.01309.
PubMed Abstract available

SOUDANI N, Bricker TL, Darling T, Seehra K, et al
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.
J Virol. 2024 Sep 4:e0052824. doi: 10.1128/jvi.00528.
PubMed Abstract available

August 2024

BARRETO-DURAN E, Synowiec A, Szczepanski A, Galuszka-Bulaga A, et al
Development of an intestinal mucosa ex vivo co-culture model to study viral infections.
J Virol. 2024 Aug 30:e0098724. doi: 10.1128/jvi.00987.
PubMed Abstract available

ALFADHLI A, Bates TA, Barklis RL, Romanaggi C, et al
A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectors.
J Virol. 2024 Aug 29:e0079524. doi: 10.1128/jvi.00795.
PubMed Abstract available

DMYTRENKO O, Das S, Kovacs A, Cicka M, et al
Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection.
J Virol. 2024 Aug 29:e0117924. doi: 10.1128/jvi.01179.
PubMed Abstract available

LIEBER CM, Kang H-J, Sobolik EB, Sticher ZM, et al
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
J Virol. 2024 Aug 29:e0090524. doi: 10.1128/jvi.00905.
PubMed Abstract available

HARTWIG SM, Odle A, Wong L-YR, Meyerholz DK, et al
Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge.
J Virol. 2024 Aug 28:e0066924. doi: 10.1128/jvi.00669.
PubMed Abstract available

YING B, Liang C-Y, Desai P, Scheaffer SM, et al
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain.
J Virol. 2024 Aug 28:e0057424. doi: 10.1128/jvi.00574.
PubMed Abstract available

ZHU J, Liu G, Sayyad Z, Goins CM, et al
ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis.
J Virol. 2024 Aug 28:e0086924. doi: 10.1128/jvi.00869.
PubMed Abstract available

TERASAKI K, Makino S
Requirement of the N-terminal region of nonstructural protein 1 in cis for SARS-CoV-2 defective RNA replication.
J Virol. 2024 Aug 28:e0090024. doi: 10.1128/jvi.00900.
PubMed Abstract available

WANG G, Verma AK, Guan X, Bu F, et al
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.
J Virol. 2024 Aug 27:e0037624. doi: 10.1128/jvi.00376.
PubMed Abstract available

BARBOSA BOMFIM CC, Genin H, Cottoignies-Callamarte A, Gallois-Montbrun S, et al
CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.
J Virol. 2024 Aug 20:e0012824. doi: 10.1128/jvi.00128.
PubMed Abstract available

QIAO S, Wang X
Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1.
J Virol. 2024;98:e0034224.
PubMed Abstract available

WANG J, Zhao Y, Cui T, Bao H, et al
AhR ligands from LGG metabolites promote piglet intestinal ILC3 activation and IL-22 secretion to inhibit PEDV infection.
J Virol. 2024;98:e0103924.
PubMed Abstract available

LOWERY SA, Schuster N, Wong L-YR, Carrillo T Jr, et al
Mouse hepatitis virus JHMV I protein is required for maximal virulence.
J Virol. 2024 Aug 19:e0068024. doi: 10.1128/jvi.00680.
PubMed Abstract available

LI J, Xiao L, Chen Z, Fan L, et al
A spike-based mRNA vaccine that induces durable and broad protection against porcine deltacoronavirus in piglets.
J Virol. 2024 Aug 19:e0053524. doi: 10.1128/jvi.00535.
PubMed Abstract available

MU Z, Whitley J, Martik D, Sutherland L, et al
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designs.
J Virol. 2024 Aug 13:e0013724. doi: 10.1128/jvi.00137.
PubMed Abstract available

RHAMADIANTI AF, Abe T, Tanaka T, Ono C, et al
SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity.
J Virol. 2024 Aug 9:e0085524. doi: 10.1128/jvi.00855.
PubMed Abstract available

ALWINE J, Goodrum F, Banfield B, Bloom D, et al
The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence.
J Virol. 2024 Aug 1:e0124024. doi: 10.1128/jvi.01240.
PubMed Abstract available

July 2024

ZHANG Y, Wu F, Han Y, Wu Y, et al
Unraveling the assembly mechanism of SADS-CoV virus nucleocapsid protein: insights from RNA binding, dimerization, and epitope diversity profiling.
J Virol. 2024 Jul 31:e0092624. doi: 10.1128/jvi.00926.
PubMed Abstract available

XIAO W, Chen C, Xia S, Li Z, et al
Cell-surface d-glucuronyl C5-epimerase binds to porcine deltacoronavirus spike protein facilitating viral entry.
J Virol. 2024 Jul 30:e0088024. doi: 10.1128/jvi.00880.
PubMed Abstract available

LI J, Zhou J, Zhang T, Wu H, et al
Effective inhibition of PDCoV infection in chimeric APN gene-edited neonatal pigs.
J Virol. 2024 Jul 30:e0061124. doi: 10.1128/jvi.00611.
PubMed Abstract available

ZHANG L, Yu R, Wang L, Zhang Z, et al
Serial cell culture passaging in vitro led to complete attenuation and changes in the characteristic features of a virulent porcine deltacoronavirus strain.
J Virol. 2024 Jul 16:e0064524. doi: 10.1128/jvi.00645.
PubMed Abstract available

RICHARDSON SI, Mzindle N, Motlou T, Manamela NP, et al
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcgammaRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
J Virol. 2024 Jul 2:e0067824. doi: 10.1128/jvi.00678.
PubMed Abstract available

JOHARINIA N, Bonneil E, Grandvaux N, Thibault P, et al
Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles.
J Virol. 2024 Jul 2:e0085024. doi: 10.1128/jvi.00850.
PubMed Abstract available

June 2024

ZHAO J, Huang Y, Liukang C, Yang R, et al
Dissecting infectious bronchitis virus-induced host shutoff at the translation level.
J Virol. 2024 Jun 28:e0083024. doi: 10.1128/jvi.00830.
PubMed Abstract available

PECHOUS RD, Malaviarachchi PA, Banerjee SK, Byrum SD, et al
An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy.
J Virol. 2024 Jun 28:e0079424. doi: 10.1128/jvi.00794.
PubMed Abstract available

CHEN Z, Cui Q, Ran Y, Achi JG, et al
A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504.
PubMed Abstract available

STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628.
PubMed Abstract available

PAN R, Li P, Meyerholz DK, Perlman S, et al
Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584.
PubMed Abstract available

ZHU J, Wang Z, Li Y, Zhang Z, et al
Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice.
J Virol. 2024 Jun 14:e0052124. doi: 10.1128/jvi.00521.
PubMed Abstract available

DAVID SC, Schaub A, Terrettaz C, Motos G, et al
Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
PubMed Abstract available

ZHANG Y, Yang N, Li Y, Tan C, et al
Transmissible gastroenteritis virus induces inflammatory responses via RIG-I/NF-kappaB/HIF-1alpha/glycolysis axis in intestinal organoids and in vivo.
J Virol. 2024;98:e0046124.
PubMed Abstract available

LI L, Li H, Qiu Y, Li J, et al
PA-824 inhibits porcine epidemic diarrhea virus infection in vivo and in vitro by inhibiting p53 activation.
J Virol. 2024 Jun 12:e0041323. doi: 10.1128/jvi.00413.
PubMed Abstract available

HU Y, Hao C, Wang D, Guo M, et al
Porcine deltacoronavirus nucleocapsid protein antagonizes JAK-STAT signaling pathway by targeting STAT1 through KPNA2 degradation.
J Virol. 2024 Jun 3:e0033424. doi: 10.1128/jvi.00334.
PubMed Abstract available

SHI J, Hu S, Wei H, Zhang L, et al
Dipeptidyl peptidase 4 interacts with porcine coronavirus PHEV spikes and mediates host range expansion.
J Virol. 2024 Jun 3:e0075324. doi: 10.1128/jvi.00753.
PubMed Abstract available

May 2024

KARMAKAR S, Das Sarma J
Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro.
J Virol. 2024 May 31:e0047824. doi: 10.1128/jvi.00478.
PubMed Abstract available

RAHMAN SM, Buchholz DW, Imbiakha B, Jager MC, et al
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
J Virol. 2024 May 30:e0006624. doi: 10.1128/jvi.00066.
PubMed Abstract available

MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
A community science approach to public health and public trust in science.
J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
PubMed Abstract available

DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
Correction for Domingo et al., "Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies".
J Virol. 2024 May 24:e0026324. doi: 10.1128/jvi.00263.
PubMed

MA MT, Jiang Q, Chen C-H, Badeti S, et al
S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
PubMed Abstract available

MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
PubMed Abstract available

CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6' active site specificity.
J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
PubMed Abstract available

ADAIR A, Tan LL, Feng J, Girkin J, et al
Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection.
J Virol. 2024 May 6:e0053124. doi: 10.1128/jvi.00531.
PubMed Abstract available

YU M, Li J, Gao W, Li Z, et al
Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
PubMed Abstract available

April 2024

VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
Harnessing the power of IFN for therapeutic approaches to COVID-19.
J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
PubMed Abstract available

MAO D, Liu S, Phan AT, Renner S, et al
The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
PubMed Abstract available

HAN Y, Yuan Z, Yi Z
Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
PubMed Abstract available

PEREZ DR
A devastating blow: personal reflections on Argentina's scientific decline.
J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
PubMed Abstract available

ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
PubMed Abstract available

WANG X, Qiu W, Hu G, Diao X, et al
NS7a of SADS-CoV promotes viral infection via inducing apoptosis to suppress type III interferon production.
J Virol. 2024 Apr 16:e0031724. doi: 10.1128/jvi.00317.
PubMed Abstract available

TAKADA K, Orba Y, Kida Y, Wu J, et al
Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
PubMed Abstract available

EBRIGHT RH, MacIntyre R, Dudley JP, Butler CD, et al
Implementing governmental oversight of enhanced potential pandemic pathogen research.
J Virol. 2024;98:e0023724.
PubMed

BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
PubMed Abstract available

ZHOU J, Sun P, Wang Y, Qiu R, et al
Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease.
J Virol. 2024 Apr 9:e0025324. doi: 10.1128/jvi.00253.
PubMed Abstract available

YANG R, Han P, Han P, Li D, et al
Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
PubMed Abstract available

XIAO X, Fu Y, You W, Huang C, et al
Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
PubMed Abstract available

BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
PubMed Abstract available

NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
PubMed Abstract available

ZHU Z, Han Y, Gong M, Sun B, et al
Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
J Virol. 2024 Apr 1:e0195723. doi: 10.1128/jvi.01957.
PubMed Abstract available

March 2024

YANG Y-L, Wang B, Li W, Cai H-L, et al
Functional dissection of the spike glycoprotein S1 subunit and identification of cellular cofactors for regulation of swine acute diarrhea syndrome coronavirus entry.
J Virol. 2024 Mar 19:e0013924. doi: 10.1128/jvi.00139.
PubMed Abstract available

MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
PubMed Abstract available

WANG T, Hu L, Li R, Ren H, et al
Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways.
J Virol. 2024 Mar 19:e0015924. doi: 10.1128/jvi.00159.
PubMed Abstract available

WANG X, Tong W, Yang X, Zhai H, et al
RBM14 inhibits the replication of porcine epidemic diarrhea virus by recruiting p62 to degrade nucleocapsid protein through the activation of autophagy and interferon pathway.
J Virol. 2024;98:e0018224.
PubMed Abstract available

LIU D, Cruz-Cosme R, Wu Y, Leibowitz J, et al
2-Bromopalmitate depletes lipid droplets to inhibit viral replication.
J Virol. 2024 Mar 15:e0017124. doi: 10.1128/jvi.00171.
PubMed Abstract available

BABOT M, Boulard Y, Agouda S, Pieri L, et al
Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
PubMed Abstract available

HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
PubMed Abstract available

ZHENG T, Shen B, Bai Y, Li E, et al
The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565.
PubMed Abstract available

February 2024

MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
PubMed Abstract available

HE H, Li Y, Chen Y, Chen J, et al
NLRP1 restricts porcine deltacoronavirus infection via IL-11 inhibiting the phosphorylation of the ERK signaling pathway.
J Virol. 2024 Feb 27:e0198223. doi: 10.1128/jvi.01982.
PubMed Abstract available

HUANG H, Lei X, Zhao C, Qin Y, et al
Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3.
J Virol. 2024;98:e0168223.
PubMed Abstract available

STOLL GA, Nikolopoulos N, Zhai H, Zhang L, et al
Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
J Virol. 2024;98:e0177723.
PubMed Abstract available

LI Z, Lai Y, Qiu R, Tang W, et al
Hyperacetylated microtubules assist porcine deltacoronavirus nsp8 to degrade MDA5 via SQSTM1/p62-dependent selective autophagy.
J Virol. 2024 Feb 14:e0000324. doi: 10.1128/jvi.00003.
PubMed Abstract available

VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
PubMed Abstract available

BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
PubMed Abstract available

NIU S, Zhao Z, Liu Z, Rong X, et al
Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157.
PubMed Abstract available

HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
PubMed Abstract available

ZHANG X-Z, Wang J, Tian W-J, You J-L, et al
Phospho-eIF4E stimulation regulates coronavirus entry by selective expression of cell membrane-residential factors.
J Virol. 2024 Feb 1:e0194823. doi: 10.1128/jvi.01948.
PubMed Abstract available

January 2024

SHEN S, Guo H, Li Y, Zhang L, et al
SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
PubMed Abstract available

LI Z, Xiao W, Yang Z, Guo J, et al
Cleavage of HDAC6 to dampen its antiviral activity by nsp5 is a common strategy of swine enteric coronaviruses.
J Virol. 2024 Jan 30:e0181423. doi: 10.1128/jvi.01814.
PubMed Abstract available

ZHANG S, Wang J, Liu X, Kan Z, et al
Pemetrexed alleviates piglet diarrhea by blocking the interaction between porcine epidemic diarrhea virus nucleocapsid protein and Ezrin.
J Virol. 2024;98:e0162523.
PubMed Abstract available

SCHMIED K, Ehmann R, Kristen-Burmann C, Ebert N, et al
An RNA replicon system to investigate promising inhibitors of feline coronavirus.
J Virol. 2024 Jan 18:e0121623. doi: 10.1128/jvi.01216.
PubMed Abstract available

DULIN H, Barre RS, Xu D, Neal A, et al
Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
PubMed Abstract available

BERTZBACH LD, Seddar L, von Stromberg K, Ip W-H, et al
The adenovirus DNA-binding protein DBP.
J Virol. 2024 Jan 10:e0188523. doi: 10.1128/jvi.01885.
PubMed Abstract available

YIN L, Liu X, Yao Y, Yuan M, et al
Gut microbiota-derived butyrate promotes coronavirus TGEV infection through impairing RIG-I-triggered local type I interferon responses via class I HDAC inhibition.
J Virol. 2024 Jan 10:e0137723. doi: 10.1128/jvi.01377.
PubMed Abstract available

FARJO M, Koelle K, Martin MA, Gibson LL, et al
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618.
PubMed Abstract available

DEY S, Mondal A
Unveiling the role of host kinases at different steps of influenza A virus life cycle.
J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
PubMed Abstract available

LI K, Verma A, Li P, Ortiz ME, et al
Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection.
J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510.
PubMed Abstract available

RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al
Virology-the path forward.
J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791.
PubMed Abstract available

December 2023

GAO Q, Weng Z, Feng Y, Gong T, et al
KPNA2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus envelope protein through selective autophagy.
J Virol. 2023;97:e0011523.
PubMed Abstract available

FU Z, Xiang Y, Fu Y, Su Z, et al
DYRK1A is a multifunctional host factor that regulates coronavirus replication in a kinase-independent manner.
J Virol. 2023 Dec 15:e0123923. doi: 10.1128/jvi.01239.
PubMed Abstract available

BOLLAND W, Michel V, Planas D, Hubert M, et al
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
PubMed Abstract available

JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al
Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
PubMed Abstract available

GAO W, Wang L, Cui W, Wang H, et al
Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function.
J Virol. 2023 Dec 12:e0143723. doi: 10.1128/jvi.01437.
PubMed Abstract available

PHAM TX, Huynh TTX, Choi J, Lee J-B, et al
SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737.
PubMed Abstract available

ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
PubMed Abstract available

SO RTY, Chu DKW, Hui KPY, Mok CKP, et al
Amino acid substitution L232F in non-structural protein 6 identified as a possible human-adaptive mutation in clade B MERS coronaviruses.
J Virol. 2023 Dec 1:e0136923. doi: 10.1128/jvi.01369.
PubMed Abstract available

November 2023

NARAYANAN KK, Amaya M, Tsang N, Yin R, et al
Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins.
J Virol. 2023;97:e0062123.
PubMed Abstract available

LI K, Huntwork RHC, Horn GQ, Abraha M, et al
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070.
PubMed Abstract available

YANG S, Huang X, Li S, Wang C, et al
Linoleic acid: a natural feed compound against porcine epidemic diarrhea disease.
J Virol. 2023 Nov 27:e0170023. doi: 10.1128/jvi.01700.
PubMed Abstract available

WANG Z, He W, Li C, Chen Y, et al
The role of lysosomes as intermediates in betacoronavirus PHEV egress from nerve cells.
J Virol. 2023 Nov 27:e0133823. doi: 10.1128/jvi.01338.
PubMed Abstract available

DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
PubMed Abstract available

BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al
Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276.
PubMed Abstract available

NIU X, Liu M, Yang S, Xu J, et al
A recombination-resistant genome for live attenuated and stable PEDV vaccines by engineering the transcriptional regulatory sequences.
J Virol. 2023 Nov 16:e0119323. doi: 10.1128/jvi.01193.
PubMed Abstract available

ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al
SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.
J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
PubMed Abstract available

October 2023

PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al
Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.
J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
PubMed Abstract available

YANG X, Kong N, Qin W, Zhai X, et al
PGAM5 degrades PDCoV N protein and activates type I interferon to antagonize viral replication.
J Virol. 2023 Oct 26:e0147023. doi: 10.1128/jvi.01470.
PubMed Abstract available

OLARTE-CASTILLO XA, Plimpton L, McQueary H, Sun Y, et al
Detection and characterization of novel luchacoviruses, genus Alphacoronavirus, in saliva and feces of meso-carnivores in the northeastern United States.
J Virol. 2023 Oct 26:e0082923. doi: 10.1128/jvi.00829.
PubMed Abstract available

UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al
Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
PubMed Abstract available

KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.
J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
PubMed Abstract available

YE G, Pan R, Bu F, Zheng J, et al
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
PubMed Abstract available

SUN H, Wang Y, Chen X, Jiang Y, et al
Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant.
J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
PubMed Abstract available

JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
PubMed Abstract available

LI J, Zhao S, Zhang B, Huang J, et al
A novel recombinant S-based subunit vaccine induces protective immunity against porcine deltacoronavirus challenge in piglets.
J Virol. 2023 Oct 17:e0095823. doi: 10.1128/jvi.00958.
PubMed Abstract available

GAO J, Tang YD, Hu W, Zheng C, et al
Correction for Gao et al., "When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2".
J Virol. 2023 Oct 16:e0098523. doi: 10.1128/jvi.00985.
PubMed

WU Y, Shi J, He X, Lu J, et al
Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.
J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
PubMed Abstract available

SUO X, Wang J, Wang D, Fan G, et al
DHA and EPA inhibit porcine coronavirus replication by alleviating ER stress.
J Virol. 2023 Oct 16:e0120923. doi: 10.1128/jvi.01209.
PubMed Abstract available

MIURA K, Suzuki Y, Ishida K, Arakawa M, et al
Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426.
PubMed Abstract available

MAHE D, Bourgeau S, da Silva J, Schlederer J, et al
SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo.
J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104.
PubMed Abstract available

RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1.
J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325.
PubMed Abstract available

FANG P, Zhang H, Cheng T, Ding T, et al
Porcine deltacoronavirus accessory protein NS6 harnesses VPS35-mediated retrograde trafficking to facilitate efficient viral infection.
J Virol. 2023 Oct 10:e0095723. doi: 10.1128/jvi.00957.
PubMed Abstract available

MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
PubMed Abstract available

KIMURA I, Yamasoba D, Nasser H, Ito H, et al
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011.
PubMed Abstract available

September 2023

CHEN Y, Liu X, Zheng JN, Yang LJ, et al
N-linked glycoproteins and host proteases are involved in swine acute diarrhea syndrome coronavirus entry.
J Virol. 2023 Sep 29:e0091623. doi: 10.1128/jvi.00916.
PubMed Abstract available

ZHAO Y, Sui L, Wu P, Li L, et al
EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8.
J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028.
PubMed Abstract available

LI J, Gui Q, Liang FX, Sall J, et al
The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507.
PubMed Abstract available

PENG Q, Fan B, Song X, He W, et al
Genetic signatures associated with the virulence of porcine epidemic diarrhea virus AH2012/12.
J Virol. 2023 Sep 21:e0106323. doi: 10.1128/jvi.01063.
PubMed Abstract available

SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al
Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii, and the megabat Rousettus aegyptiacus, and their response to SARS-CoV-2 infection.
J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205.
PubMed Abstract available

FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al
Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.
J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990.
PubMed Abstract available

KRCHLIKOVA V, Lotke R, Haussmann I, Reinisova M, et al
Independent loss events of a functional tetherin gene in galliform birds.
J Virol. 2023 Sep 15:e0080323. doi: 10.1128/jvi.00803.
PubMed Abstract available

XING M, Wang Y, Wang X, Liu J, et al
Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
PubMed Abstract available

DAHAL S, Clayton K, Cabral T, Cheng R, et al
On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine.
J Virol. 2023 Sep 14:e0039623. doi: 10.1128/jvi.00396.
PubMed Abstract available

KERR CM, Parthasarathy S, Schwarting N, O'Connor JJ, et al
PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner.
J Virol. 2023 Sep 11:e0088523. doi: 10.1128/jvi.00885.
PubMed Abstract available

LI Z, Ma Z, Han W, Chang C, et al
Deletion of a 7-amino-acid region in the porcine epidemic diarrhea virus envelope protein induces higher type I and III interferon responses and results in attenuation in vivo.
J Virol. 2023 Sep 8:e0084723. doi: 10.1128/jvi.00847.
PubMed Abstract available

HAN P, Meng Y, Zhang D, Xu Z, et al
Structural basis of white-tailed deer, Odocoileus virginianus, ACE2 recognizing all the SARS-CoV-2 variants of concern with high affinity.
J Virol. 2023 Sep 7:e0050523. doi: 10.1128/jvi.00505.
PubMed Abstract available

CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628.
PubMed Abstract available

LIU Y, Chen D, Wang Y, Li X, et al
Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry.
J Virol. 2023 Sep 7:e0060123. doi: 10.1128/jvi.00601.
PubMed Abstract available

DANIELS A, Fletcher S, Kerr HEM, Kratzel A, et al
One for all-human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses.
J Virol. 2023 Sep 5:e0055523. doi: 10.1128/jvi.00555.
PubMed Abstract available

GUO H, Li A, Dong TY, Si HR, et al
Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats.
J Virol. 2023 Sep 1:e0039523. doi: 10.1128/jvi.00395.
PubMed Abstract available

August 2023

LIN HF, Liu MQ, Jiang RD, Gong QC, et al
Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790.
PubMed Abstract available

LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
PubMed Abstract available

JIN H, Cheng L, Gong Y, Zhu Y, et al
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
PubMed Abstract available

ZHANG W, Shi K, Geng Q, Herbst M, et al
Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
PubMed Abstract available

LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
PubMed Abstract available

MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
PubMed Abstract available

July 2023

SHARMA M, Chakravarty D, Hussain A, Zalavadia A, et al
Ifit2 restricts murine coronavirus spread to the spinal cord white matter and its associated myelin pathology.
J Virol. 2023 Jul 28:e0074923. doi: 10.1128/jvi.00749.
PubMed Abstract available

JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
PubMed Abstract available

June 2023

YANG X, Duan H, Liu X, Zhang X, et al
Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
PubMed Abstract available

TERASAKI K, Narayanan K, Makino S
Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
PubMed Abstract available

KRISTEN-BURMANN C, Rogger P, Veiga IB, Riebesehl S, et al
Reverse Genetic Assessment of the Roles Played by the Spike Protein and ORF3 in Porcine Epidemic Diarrhea Virus Pathogenicity.
J Virol. 2023 Jun 26:e0196422. doi: 10.1128/jvi.01964.
PubMed Abstract available

LI A, Zhang B, Zhao K, Yin Z, et al
SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
PubMed Abstract available

GOFFIN E, Du X, Hemmi S, Machiels B, et al
A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
PubMed Abstract available

ZHANG S, Zhang S, Hou Y, Huang Y, et al
Porcine Deltacoronavirus Infection Disrupts the Intestinal Mucosal Barrier and Inhibits Intestinal Stem Cell Differentiation to Goblet Cells via the Notch Signaling Pathway.
J Virol. 2023 Jun 8:e0068923. doi: 10.1128/jvi.00689.
PubMed Abstract available

May 2023

HE H, Wang W, Li L, Zhang X, et al
Activation of the NLRP1 Inflammasome and Its Role in Transmissible Gastroenteritis Coronavirus Infection.
J Virol. 2023 May 31:e0058923. doi: 10.1128/jvi.00589.
PubMed Abstract available

ZHOU C, Liu Y, Wei Q, Chen Y, et al
HSPA5 Promotes Attachment and Internalization of Porcine Epidemic Diarrhea Virus through Interaction with the Spike Protein and the Endo-/Lysosomal Pathway.
J Virol. 2023 May 24:e0054923. doi: 10.1128/jvi.00549.
PubMed Abstract available

SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
PubMed Abstract available

JIANG H, Joshi A, Gan T, Janowski AB, et al
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
PubMed Abstract available

ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
PubMed Abstract available

SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
PubMed Abstract available

LI Z, Duan P, Qiu R, Fang L, et al
HDAC6 Degrades nsp8 of Porcine Deltacoronavirus through Deacetylation and Ubiquitination to Inhibit Viral Replication.
J Virol. 2023 May 3:e0037523. doi: 10.1128/jvi.00375.
PubMed Abstract available

GUO X, Feng Y, Zhao X, Qiao S, et al
Coronavirus Porcine Epidemic Diarrhea Virus Utilizes Chemokine Interleukin-8 to Facilitate Viral Replication by Regulating Ca(2+) Flux.
J Virol. 2023 May 3:e0029223. doi: 10.1128/jvi.00292.
PubMed Abstract available

April 2023

YOU R, Liu K, Huang M, Tang L, et al
Identification and Comparison of the Sialic Acid-Binding Domain Characteristics of Avian Coronavirus Infectious Bronchitis Virus Spike Protein.
J Virol. 2023 Apr 25:e0048923. doi: 10.1128/jvi.00489.
PubMed Abstract available

SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.
PubMed

KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
PubMed Abstract available

March 2023

JI Z, Dong H, Jiao R, Zhu X, et al
The TGEV Membrane Protein Interacts with HSC70 To Direct Virus Internalization through Clathrin-Mediated Endocytosis.
J Virol. 2023 Mar 28:e0012823. doi: 10.1128/jvi.00128.
PubMed Abstract available

CHEN XN, Liang YF, Weng ZJ, Quan WP, et al
Porcine Enteric Alphacoronavirus Entry through Multiple Pathways (Caveolae, Clathrin, and Macropinocytosis) Requires Rab GTPases for Endosomal Transport.
J Virol. 2023 Mar 28:e0021023. doi: 10.1128/jvi.00210.
PubMed Abstract available

ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
PubMed Abstract available

WANG X, Wang W, Wang T, Wang J, et al
SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
PubMed Abstract available

DUAN Y, Yuan C, Suo X, Li Y, et al
Bat-Origin Swine Acute Diarrhea Syndrome Coronavirus Is Lethal to Neonatal Mice.
J Virol. 2023 Mar 6:e0019023. doi: 10.1128/jvi.00190.
PubMed Abstract available

MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
PubMed Abstract available

February 2023

FROLOV I, Agback T, Palchevska O, Dominguez F, et al
All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
PubMed Abstract available

QIN W, Qi X, Xie Y, Wang H, et al
LncRNA446 Regulates Tight Junctions by Inhibiting the Ubiquitinated Degradation of Alix after Porcine Epidemic Diarrhea Virus Infection.
J Virol. 2023 Feb 15:e0188422. doi: 10.1128/jvi.01884.
PubMed Abstract available

ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
PubMed Abstract available

WANG X, Wen Z, Cao H, Luo J, et al
Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
PubMed Abstract available

KEEP S, Dowgier G, Lulla V, Britton P, et al
Deletion of the s2m RNA Structure in the Avian Coronavirus Infectious Bronchitis Virus and Human Astrovirus Results in Sequence Insertions.
J Virol. 2023 Feb 13:e0003823. doi: 10.1128/jvi.00038.
PubMed Abstract available

AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
PubMed Abstract available

ZHOU H, Yan Y, Gao J, Ma M, et al
Heterogeneous Nuclear Protein U Degraded the m(6)A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.
J Virol. 2023 Feb 8:e0175122. doi: 10.1128/jvi.01751.
PubMed Abstract available

LIN J, Law R, Korosec CS, Zhou C, et al
Erratum for Lin et al., "Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity".
J Virol. 2023 Feb 7:e0008023. doi: 10.1128/jvi.00080.
PubMed

BEI C, Zhang C, Wu H, Feng H, et al
DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
PubMed Abstract available

SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
PubMed Abstract available

January 2023

ZHAI X, Kong N, Wang C, Qin W, et al
PRPF19 Limits Porcine Epidemic Diarrhea Virus Replication through Targeting and Degrading Viral Capsid Protein.
J Virol. 2023;97:e0161422.
PubMed Abstract available

GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
Virology under the Microscope-a Call for Rational Discourse.
J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
PubMed Abstract available

LIU MQ, Lin HF, Li J, Chen Y, et al
A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
PubMed Abstract available

RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
PubMed Abstract available

LIANG QZ, Wang B, Ji CM, Hu F, et al
Chicken or Porcine Aminopeptidase N Mediates Cellular Entry of Pseudoviruses Carrying Spike Glycoprotein from the Avian Deltacoronaviruses HKU11, HKU13, and HKU17.
J Virol. 2023 Jan 19:e0194722. doi: 10.1128/jvi.01947.
PubMed Abstract available

MA J, Liu X, Zhou M, Chen P, et al
A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
PubMed Abstract available

SHIWA-SUDO N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, et al
Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
J Virol. 2023 Jan 12:e0136622. doi: 10.1128/jvi.01366.
PubMed Abstract available

December 2022

CHANG P, Lukosaityte D, Sealy JE, Rijal P, et al
Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
J Virol. 2022 Dec 21:e0143122. doi: 10.1128/jvi.01431.
PubMed Abstract available

CHEN Y, Wu Y, Chen S, Zhan Q, et al
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
PubMed Abstract available

WANG X, Jin Q, Xiao W, Fang P, et al
Genome-Wide CRISPR/Cas9 Screen Reveals a Role for SLC35A1 in the Adsorption of Porcine Deltacoronavirus.
J Virol. 2022 Dec 1:e0162622. doi: 10.1128/jvi.01626.
PubMed Abstract available

November 2022

CHOI SSA, Chan HH, Chan CM, Wang X, et al
Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.
J Virol. 2022 Nov 30:e0141822. doi: 10.1128/jvi.01418.
PubMed Abstract available

BELSER JA, Sun X, Kieran TJ, Brock N, et al
Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
J Virol. 2022 Nov 30:e0140322. doi: 10.1128/jvi.01403.
PubMed Abstract available

XUE M, Wang W, He H, Li L, et al
Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production.
J Virol. 2022 Nov 30:e0138822. doi: 10.1128/jvi.01388.
PubMed Abstract available

NIU Z, Xu S, Zhang Y, Kan Z, et al
Transmissible Gastroenteritis Virus Nucleocapsid Protein Interacts with Na(+)/H(+) Exchanger 3 To Reduce Na(+)/H(+) Exchanger Activity and Promote Piglet Diarrhea.
J Virol. 2022;96:e0147322.
PubMed Abstract available

TAN TS, Toyoda M, Ode H, Barabona G, et al
Erratum for Tan et al., "Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike".
J Virol. 2022 Nov 21:e0173722. doi: 10.1128/jvi.01737.
PubMed

LISTA MJ, Winstone H, Wilson HD, Dyer A, et al
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
J Virol. 2022 Nov 9:e0125022. doi: 10.1128/jvi.01250.
PubMed Abstract available

WANG X, Kerkmann L, Hetzel M, Windmann S, et al
Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
J Virol. 2022 Nov 7:e0113322. doi: 10.1128/jvi.01133.
PubMed Abstract available

CZERKIES M, Kochanczyk M, Korwek Z, Prus W, et al
Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
J Virol. 2022 Nov 3:e0134122. doi: 10.1128/jvi.01341.
PubMed Abstract available

QIN W, Kong N, Wang C, Dong S, et al
hnRNP K Degrades Viral Nucleocapsid Protein and Induces Type I IFN Production to Inhibit Porcine Epidemic Diarrhea Virus Replication.
J Virol. 2022 Nov 1:e0155522. doi: 10.1128/jvi.01555.
PubMed Abstract available

October 2022

LAU SKP, Poon RWS, Wong BHL, Wang M, et al
Retraction for Lau et al., "Coexistence of Different Genotypes in the Same Bat and Serological Characterization of Rousettus Bat Coronavirus HKU9 Belonging to a Novel Betacoronavirus Subgroup".
J Virol. 2022 Oct 31:e0148522. doi: 10.1128/jvi.01485.
PubMed

WOO PCY, Lau SKP, Lam CSF, Tsang AKL, et al
Retraction for Woo et al., "Discovery of a Novel Bottlenose Dolphin Coronavirus Reveals a Distinct Species of Marine Mammal Coronavirus in Gammacoronavirus".
J Virol. 2022 Oct 31:e0150322. doi: 10.1128/jvi.01503.
PubMed

SIU KL, Yeung ML, Kok KH, Yuen KS, et al
Retraction for Siu et al., "Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response".
J Virol. 2022 Oct 31:e0150422. doi: 10.1128/jvi.01504.
PubMed

SACCO MT, Bland KM, Horner SM
WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
PubMed Abstract available

TAN TS, Toyoda M, Ode H, Barabona G, et al
Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
J Virol. 2022 Oct 10:e0116222. doi: 10.1128/jvi.01162.
PubMed Abstract available

September 2022

CHEN M, Wang MH, Shen XG, Liu H, et al
Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner.
J Virol. 2022 Sep 29:e0131822. doi: 10.1128/jvi.01318.
PubMed Abstract available

YANG N, Zhang Y, Fu Y, Li Y, et al
Transmissible Gastroenteritis Virus Infection Promotes the Self-Renewal of Porcine Intestinal Stem Cells via Wnt/beta-Catenin Pathway.
J Virol. 2022;96:e0096222.
PubMed Abstract available

GELLENONCOURT S, Saunders N, Robinot R, Auguste L, et al
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
J Virol. 2022 Sep 19:e0130122. doi: 10.1128/jvi.01301.
PubMed Abstract available

AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
PubMed Abstract available

August 2022

ZHANG C, Cui H, Guo Z, Chen Z, et al
SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
J Virol. 2022 Aug 30:e0103422. doi: 10.1128/jvi.01034.
PubMed Abstract available

FAN B, Peng Q, Song S, Shi D, et al
Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.
J Virol. 2022 Aug 29:e0102422. doi: 10.1128/jvi.01024.
PubMed Abstract available

MARTINS M, do Nascimento GM, Nooruzzaman M, Yuan F, et al
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
J Virol. 2022 Aug 24:e0096122. doi: 10.1128/jvi.00961.
PubMed Abstract available

SU C, He J, Han P, Bai B, et al
Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
J Virol. 2022 Aug 24:e0081422. doi: 10.1128/jvi.00814.
PubMed Abstract available

KAZEMI S, Lopez-Munoz AD, Holly J, Jin L, et al
Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
J Virol. 2022 Aug 24:e0025622. doi: 10.1128/jvi.00256.
PubMed Abstract available

JIAO Z, Yan Y, Chen Y, Wang G, et al
Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
PubMed Abstract available

NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
PubMed Abstract available

CHEN Y, Jiang RD, Wang Q, Luo Y, et al
Lethal Swine Acute Diarrhea Syndrome Coronavirus Infection in Suckling Mice.
J Virol. 2022 Aug 22:e0006522. doi: 10.1128/jvi.00065.
PubMed Abstract available

ZHOU Y, Zheng R, Liu D, Liu S, et al
UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
J Virol. 2022 Aug 18:e0074122. doi: 10.1128/jvi.00741.
PubMed Abstract available

GUPTA SL, Mantus G, Manning KE, Ellis M, et al
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
PubMed Abstract available

KEEP S, Stevenson-Leggett P, Dowgier G, Foldes K, et al
A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.
J Virol. 2022 Aug 16:e0110022. doi: 10.1128/jvi.01100.
PubMed Abstract available

YUAN C, Suo X, Duan Y, Li X, et al
Comprehensive Subcellular Localization of Swine Acute Diarrhea Syndrome Coronavirus Proteins.
J Virol. 2022 Aug 16:e0077222. doi: 10.1128/jvi.00772.
PubMed Abstract available

HAN Y, Bai X, Liu S, Zhu J, et al
XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
J Virol. 2022 Aug 16:e0077422. doi: 10.1128/jvi.00774.
PubMed Abstract available

SHI J, Zheng J, Tai W, Verma AK, et al
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
PubMed Abstract available

UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
PubMed Abstract available

VETTER J, Papa G, Seyffert M, Gunasekera K, et al
Rotavirus Spike Protein VP4 Mediates Viroplasm Assembly by Association to Actin Filaments.
J Virol. 2022 Aug 8:e0107422. doi: 10.1128/jvi.01074.
PubMed Abstract available

ANDERSON-DANIELS J, Gribble J, Denison M
Proteolytic Processing of the Coronavirus Replicase Nonstructural Protein 14 Exonuclease Is Not Required for Virus Replication but Alters RNA Synthesis and Viral Fitness.
J Virol. 2022 Aug 4:e0084122. doi: 10.1128/jvi.00841.
PubMed Abstract available

ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
PubMed Abstract available

CAMPAGNOLA G, Govindarajan V, Pelletier A, Canard B, et al
The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication.
J Virol. 2022 Aug 4:e0067122. doi: 10.1128/jvi.00671.
PubMed Abstract available

ZHAN W, Tian X, Zhang X, Xing S, et al
Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
PubMed Abstract available

LI Z, Fang P, Duan P, Chen J, et al
Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
PubMed Abstract available

YUAN M, Chen X, Zhu Y, Dong X, et al
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
PubMed Abstract available

July 2022

FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
PubMed Abstract available

AKAISHI T, Horii A, Ishii T
Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
PubMed

GUO H, Li A, Lin HF, Liu MQ, et al
The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
PubMed Abstract available

MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
PubMed Abstract available

DONG S, Kong N, Wang C, Li Y, et al
FUBP3 Degrades the Porcine Epidemic Diarrhea Virus Nucleocapsid Protein and Induces the Production of Type I Interferon.
J Virol. 2022;96:e0061822.
PubMed Abstract available

PUSNIK J, Konig J, Mai K, Richter E, et al
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
PubMed Abstract available

CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
PubMed Abstract available

OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
PubMed Abstract available

AICHER SM, Streicher F, Chazal M, Planas D, et al
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
J Virol. 2022 Jul 5:e0060822. doi: 10.1128/jvi.00608.
PubMed Abstract available

XING N, Wang Z, Wang J, Nascimento M, et al
Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene.
J Virol. 2022 Jul 5:e0065322. doi: 10.1128/jvi.00653.
PubMed Abstract available

June 2022

VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
PubMed

JIANG C, Li L, Xue M, Zhao L, et al
Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
PubMed Abstract available

DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
PubMed Abstract available

YUAN C, Zhang P, Liu P, Li Y, et al
A Novel Pathway for Porcine Epidemic Diarrhea Virus Transmission from Sows to Neonatal Piglets Mediated by Colostrum.
J Virol. 2022 Jun 27:e0047722. doi: 10.1128/jvi.00477.
PubMed Abstract available

BI W, Chen G, Dang B
Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
PubMed Abstract available

CHAN CE, Ng CG, Lim AP, Seah SL, et al
The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
PubMed Abstract available

LIN J, Law R, Korosec CS, Zhou C, et al
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
PubMed Abstract available

SUN C, Yuan RY, Xie C, Sun JF, et al
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
PubMed Abstract available

LAVIE M, Dubuisson J, Belouzard S
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
PubMed Abstract available

SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
PubMed Abstract available

ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".
J Virol. 2022 Jun 6:e0074522. doi: 10.1128/jvi.00745.
PubMed

CHEN X, Li J, Yang L, Zhou Y, et al
Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
PubMed Abstract available

LIU H, Bai Y, Zhang X, Gao T, et al
SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
PubMed Abstract available

May 2022

ZHAO J, Feng D, Zhao Y, Huang M, et al
Role of Stress Granules in Suppressing Viral Replication by the Infectious Bronchitis Virus Endoribonuclease.
J Virol. 2022 May 31:e0068622. doi: 10.1128/jvi.00686.
PubMed Abstract available

DIJKMAN R, Verma AK, Selvaraj M, Ghimire R, et al
Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
J Virol. 2022 May 19:e0036422. doi: 10.1128/jvi.00364.
PubMed Abstract available

NIU X, Kong F, Xu J, Liu M, et al
Mutations in Porcine Epidemic Diarrhea Virus nsp1 Cause Increased Viral Sensitivity to Host Interferon Responses and Attenuation In Vivo.
J Virol. 2022 May 18:e0046922. doi: 10.1128/jvi.00469.
PubMed Abstract available

NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
PubMed Abstract available

DONG S, Kong N, Zhang Y, Li Y, et al
TARDBP Inhibits Porcine Epidemic Diarrhea Virus Replication through Degrading Viral Nucleocapsid Protein and Activating Type I Interferon Signaling.
J Virol. 2022 May 2:e0007022. doi: 10.1128/jvi.00070.
PubMed Abstract available

April 2022

ZHANG J, Yuan S, Peng Q, Ding Z, et al
Porcine Epidemic Diarrhea Virus nsp7 Inhibits Interferon-Induced JAK-STAT Signaling through Sequestering the Interaction between KPNA1 and STAT1.
J Virol. 2022 Apr 20:e0040022. doi: 10.1128/jvi.00400.
PubMed Abstract available

LI J, Li Y, Liu P, Wang X, et al
Porcine Epidemic Diarrhea Virus Infection Disrupts the Nasal Endothelial Barrier To Favor Viral Dissemination.
J Virol. 2022 Apr 18:e0038022. doi: 10.1128/jvi.00380.
PubMed Abstract available

ZHENG XS, Wang Q, Min J, Shen XR, et al
Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
PubMed Abstract available

AGUILAR EG, Paniccia G, Adura C, Singer ZS, et al
Sindbis Macrodomain Poly-ADP-Ribose Hydrolase Activity Is Important for Viral RNA Synthesis.
J Virol. 2022;96:e0151621.
PubMed Abstract available

DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
PubMed Abstract available

LANGLEY WA, Wieland A, Ahmed H, Rasheed MAU, et al
Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
J Virol. 2022 Apr 11:e0002622. doi: 10.1128/jvi.00026.
PubMed Abstract available

CHEN J, Li Z, Guo J, Xu S, et al
SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
PubMed Abstract available

FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
PubMed Abstract available

LI J, Lin C, Zhou X, Zhong F, et al
Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
PubMed Abstract available

KLASSE PJ, Moore JP
Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
PubMed Abstract available

March 2022

HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
PubMed Abstract available

ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
PubMed Abstract available

GENG Q, Shi K, Ye G, Zhang W, et al
Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
PubMed Abstract available

LIU MQ, Jiang RD, Guo J, Chen Y, et al
Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
PubMed Abstract available

XIANG J, Lu M, Shi M, Cheng X, et al
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
PubMed Abstract available

LIU X, Yin L, Xue M, Chen J, et al
Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.
J Virol. 2022 Mar 21:e0015822. doi: 10.1128/jvi.00158.
PubMed Abstract available

REINECKE B, Frericks N, Lauber C, Dinkelborg K, et al
The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
J Virol. 2022 Mar 17:e0199521. doi: 10.1128/jvi.01995.
PubMed Abstract available

BERKHOUT B, Herrera-Carrillo E
SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
PubMed Abstract available

GAO J, Tang YD, Hu W, Zheng C, et al
When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
PubMed Abstract available

METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
PubMed Abstract available

LI M, Wu Y, Chen J, Shi H, et al
Innate Immune Evasion of Porcine Epidemic Diarrhea Virus through Degradation of the FBXW7 Protein via the Ubiquitin-Proteasome Pathway.
J Virol. 2022;96:e0088921.
PubMed Abstract available

February 2022

JUNG C, Kmiec D, Koepke L, Zech F, et al
Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
PubMed Abstract available

December 2021

ETTICH J, Werner J, Weitz HT, Mueller E, et al
A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.